4//SEC Filing
Musso Alan A 4
Accession 0001358403-17-000169
CIK 0001358403other
Filed
Nov 28, 7:00 PM ET
Accepted
Nov 29, 5:06 PM ET
Size
5.6 KB
Accession
0001358403-17-000169
Insider Transaction Report
Form 4
Musso Alan A
CFO and Treasurer
Transactions
- Sale
Common Stock
2017-11-27$9.89/sh+6,206$61,382→ 48,702 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person on June 7, 2017.
- [F2]Represents shares sold to satisfy tax liabilities and withholding obligations in connection with vesting of 14,706 shares of common stock from the Restricted Stock Awards granted to the Reporting Person on December 17, 2014.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.85 to $9.97. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the range set forth above.
Documents
Issuer
BELLICUM PHARMACEUTICALS, INC
CIK 0001358403
Entity typeother
Related Parties
1- filerCIK 0001295830
Filing Metadata
- Form type
- 4
- Filed
- Nov 28, 7:00 PM ET
- Accepted
- Nov 29, 5:06 PM ET
- Size
- 5.6 KB